Unnamed stage
Our 4th newsletter detailing our investment in Qubigen
Synthesis BioVentures' fourth newsletter covers its backing of Qubigen; the captured page holds only a title and date, with no further detail.
Company
Every investor coverage indicates participated in a round Qubigen raised.
Companies Qubigen acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Qubigen. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Synthesis BioVentures' fourth newsletter covers its backing of Qubigen; the captured page holds only a title and date, with no further detail.